Contact
Please use this form to send email to PR contact of this press release:
Georgiamune Announces First Patient Dosed in A First-In-Class Phase 1 Cancer Treatment Trial of GIM-531
TO:
Please use this form to send email to PR contact of this press release:
Georgiamune Announces First Patient Dosed in A First-In-Class Phase 1 Cancer Treatment Trial of GIM-531
TO: